-
52012AR2203
Opinion of the Committee of the Regions on ‘Blue growth: opportunities for marine and maritime sustainable growth’
OJ C 62, 2.3.2013, p. 47–50 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
22002A0731(01)R(01)
This corrigendum does not concern the English version.
-
52012DC0582
COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS A Stronger European Industry for Growth and Economic Recovery Industrial Policy Communication Update
/* COM/2012/0582 final */
-
52012DC0494
COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS Blue Growth opportunities for marine and maritime sustainable growth
/* COM/2012/0494 final */
-
62010CA0034
Case C-34/10: Judgment of the Court (Grand Chamber) of 18 October 2011 (reference for a preliminary ruling from the Bundesgerichtshof — Germany) — Oliver Brüstle v Greenpeace e.V. (Directive 98/44/EC — Article 6(2)(c) — Legal protection of biotechnological inventions — Extraction of precursor cells from human embryonic stem cells — Patentability — Exclusion of ‘uses of human embryos for industrial or commercial purposes’ — Concepts of ‘human embryo’ and ‘use for industrial or commercial purposes’ )
OJ C 362, 10.12.2011, p. 5–6 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
92011E011258
Written question E-011258/11 Anne Delvaux (PPE) to the Commission. Patentability of plants and animals
The title of this written question was published in
OJ C 180E, 21.6.2012
-
92011E010481
Written question E-010481/11 Michael Cashman (S&D) and Glenis Willmott (S&D) to the Commission. EU patent ban on stem cell research
The title of this written question was published in
OJ C 168E, 14.6.2012
-
92011E008673
Written question E-008673/11 Michail Tremopoulos (Verts/ALE) to the Commission. Pharmaceutical residues in waterways
The title of this written question was published in
OJ C 154E, 31.5.2012
-
52011DC0366
COMMUNICATION FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT Renewal of the Arrangement between the European Commission and the Office of Science and Technology Policy of the United States of America establishing a Task Force on Biotechnology Research
/* COM/2011/0366 final */
-
92011E005620
Written question E-005620/11 Thomas Ulmer (PPE) to the Commission. Consultation in view of the revision of Directive 2001/20/EC on clinical trials
The title of this written question was published in
OJ C 365E, 15.12.2011
|
